Inflammatory reaction after sirolimus-eluting stent implant

Ann Thorac Surg. 2005 Nov;80(5):1903-4. doi: 10.1016/j.athoracsur.2004.05.079.

Abstract

Sirolimus-eluting stents (SES) are supposed to attenuate cell proliferation and reduce restenosis rate. Histologic finding from coronary artery after SES implant showed fibrosis and inflammatory infiltrate, revealing a chronic inflammatory reaction. Extension of coronary inflammatory reaction after stenting needs clarification. The long-term consequences are unknown.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Coronary Artery Bypass
  • Coronary Restenosis / prevention & control*
  • Female
  • Humans
  • Inflammation / etiology*
  • Inflammation / physiopathology
  • Male
  • Middle Aged
  • Sirolimus / therapeutic use*
  • Stents / adverse effects*

Substances

  • Anti-Bacterial Agents
  • Sirolimus